Genomic Vision Gets $344K Grant for MDx Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Vision, a Paris-based molecular diagnostics firm, has received a €250,000 ($344,000) grant from the Association Française contre les Myopathies (AFM) for the optimization and validation of a diagnostic test for facio-scapulo-humeral dystrophy (FSHD).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.